|Bid||455.11 x 800|
|Ask||493.00 x 1000|
|Day's Range||470.53 - 476.82|
|52 Week Range||355.43 - 533.68|
|Beta (5Y Monthly)||0.90|
|PE Ratio (TTM)||19.04|
|Earnings Date||Oct 18, 2022 - Oct 24, 2022|
|Forward Dividend & Yield||5.12 (1.08%)|
|Ex-Dividend Date||Sept 08, 2022|
|1y Target Est||546.74|
BETHESDA, Md. & INDIANAPOLIS, August 02, 2022--Elevance Health, (NYSE: ELV), one of the nation’s leading health companies, and Aledade, an innovative primary care physician enablement company, today announced a partnership that will help enhance the consumer experience and health outcomes for those seeking services from independent primary care practices. The partnership centers on assisting independent primary care physicians across the country transition to value-based care, which is proven to
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Elevance Health (ELV) is well positioned to outperform the market, as it exhibits above-average growth in financials.